Can residual disease be diagnosed with image-guided vacuum-assisted breast biopsy?

The pathologic evaluation of surgical specimens is the gold standard for diagnosing residual disease and pathologic complete response following neoadjuvant chemotherapy for breast cancer, but this approach can lead to over-treatment, according to Joerg Heil, MD.
Read More

No long-term benefit to sentinel lymph node biopsy in most DCIS patients

Clinical practice guidelines are clear that sentinel lymph node biopsy (SLNB) is not warranted in most cases of ductal carcinoma in situ (DCIS).
Read More

Recurrence scores spare some patients from chemotherapy

Recurrence scores spare some patients from chemotherapy.
Read More